Working... Menu

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03771963
Recruitment Status : Active, not recruiting
First Posted : December 11, 2018
Last Update Posted : June 21, 2019
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 12, 2019
  Estimated Study Completion Date : March 16, 2020